B & T Capital Management DBA Alpha Capital Management purchased a new stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 12,399 shares of the financial services provider’s stock, valued at approximately $1,283,000.
A number of other hedge funds also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC purchased a new position in Aflac in the 3rd quarter worth about $34,000. Raelipskie Partnership bought a new stake in shares of Aflac in the third quarter worth approximately $38,000. Covestor Ltd raised its holdings in shares of Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after purchasing an additional 107 shares during the last quarter. Kennebec Savings Bank bought a new position in Aflac during the third quarter valued at approximately $45,000. Finally, Catalyst Capital Advisors LLC purchased a new stake in Aflac in the third quarter worth approximately $51,000. 67.44% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Aflac
In related news, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the transaction, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.80% of the company’s stock.
Aflac Stock Up 0.5 %
Aflac (NYSE:AFL – Get Free Report) last released its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.69 by $0.47. The firm had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The company’s quarterly revenue was down 40.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.84 earnings per share. On average, sell-side analysts forecast that Aflac Incorporated will post 7.26 earnings per share for the current fiscal year.
Aflac Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be given a dividend of $0.58 per share. This is a positive change from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Wednesday, February 19th. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.18%. Aflac’s dividend payout ratio (DPR) is presently 30.12%.
Analysts Set New Price Targets
Several analysts recently commented on the company. JPMorgan Chase & Co. lifted their price objective on Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a report on Tuesday, January 7th. Evercore ISI cut their price target on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday, December 4th. Keefe, Bruyette & Woods reduced their price target on shares of Aflac from $108.00 to $107.00 and set a “market perform” rating for the company in a research report on Friday, January 10th. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a report on Wednesday, January 8th. Finally, Truist Financial upped their target price on shares of Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a report on Friday, November 1st. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $102.07.
Get Our Latest Analysis on AFL
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- Stock Market Upgrades: What Are They?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Profitably Trade Stocks at 52-Week Highs
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- How to Use the MarketBeat Stock Screener
- MarketBeat Week in Review – 01/13 – 01/17
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.